Common Reference-Based Tandem Mass Tag Multiplexing for the Relative Quantification of Peptides: Design and Application to Degradome Analysis of Diphtheria Toxoid
- PMID: 33983728
- PMCID: PMC8176455
- DOI: 10.1021/jasms.1c00070
Common Reference-Based Tandem Mass Tag Multiplexing for the Relative Quantification of Peptides: Design and Application to Degradome Analysis of Diphtheria Toxoid
Abstract
Currently, animal tests are being used to confirm the potency and lack of toxicity of toxoid vaccines. In a consistency approach, animal tests could be replaced if production consistency (compared to known good products) can be proven in a panel of in vitro assays. By mimicking the in vivo antigen processing in a simplified in vitro approach, it may be possible to distinguish aberrant products from good products. To demonstrate this, heat-exposed diphtheria toxoid was subjected to partial digestion by cathepsin S (an endoprotease involved in antigen processing), and the peptide formation/degradation kinetics were mapped for various heated toxoids. To overcome the limitations associated with the very large number of samples, we used common reference-based tandem mass tag (TMT) labeling. Instead of using one label per condition with direct comparison between the set of labels, we compared multiple labeled samples to a common reference (a pooled sample containing an aliquot of each condition). In this method, the number of samples is not limited by the number of unique TMT labels. This TMT multiplexing strategy allows for a 15-fold reduction of analysis time while retaining the reliability advantage of TMT labeling over label-free quantification. The formation of the most important peptides could be followed over time and compared among several conditions. The changes in enzymatic degradation kinetics of diphtheria toxoid revealed several suitable candidate peptides for use in a quality control assay that can distinguish structurally aberrant diphtheria toxoid from compliant toxoids.
Keywords: degradomics; diphtheria toxoid; enzyme kinetics; proteomics; tandem mass tag multiplexing; vaccine quality control.
Conflict of interest statement
The authors declare no competing financial interest.
Figures




References
-
- Hartman I. Z.; Kim A.; Cotter R. J.; Walter K.; Dalai S. K.; Boronina T.; Griffith W.; Lanar D. E.; Schwenk R.; Krzych U.; Cole R. N.; Sadegh-Nasseri S. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nat. Med. 2010, 16 (11), 1333–40. 10.1038/nm.2248. - DOI - PMC - PubMed
-
- Schulten V.; Nagl B.; Scala E.; Bernardi M. L.; Mari A.; Ciardiello M. A.; Lauer I.; Scheurer S.; Briza P.; Jurets A.; Ferreira F.; Jahn-Schmid B.; Fischer G. F.; Bohle B. Pru p 3, the nonspecific lipid transfer protein from peach, dominates the immune response to its homolog in hazelnut. Allergy 2011, 66 (8), 1005–13. 10.1111/j.1398-9995.2011.02567.x. - DOI - PubMed
-
- Ackaert C.; Kofler S.; Horejs-Hoeck J.; Zulehner N.; Asam C.; von Grafenstein S.; Fuchs J. E.; Briza P.; Liedl K. R.; Bohle B.; Ferreira F.; Brandstetter H.; Oostingh G. J.; Duschl A. The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101. PLoS One 2014, 9 (8), e10452010.1371/journal.pone.0104520. - DOI - PMC - PubMed
-
- Machado Y.; Freier R.; Scheiblhofer S.; Thalhamer T.; Mayr M.; Briza P.; Grutsch S.; Ahammer L.; Fuchs J. E.; Wallnoefer H. G.; Isakovic A.; Kohlbauer V.; Hinterholzer A.; Steiner M.; Danzer M.; Horejs-Hoeck J.; Ferreira F.; Liedl K. R.; Tollinger M.; Lackner P.; Johnson C. M.; Brandstetter H.; Thalhamer J.; Weiss R. Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen. J. Allergy Clin. Immunol. 2016, 137 (5), 1525–34. 10.1016/j.jaci.2015.09.026. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources